Comprehensive newborn genetic screening for early onset diseases.


One-Time Payment

Deep Dive

Why Screen My Baby's Genomics?


How it Works

Why is Genomic Screening for Newborns Important?

MyNewborn is a genetic screening test that analyses the newborn ́s DNA through Whole Exome Sequencing (WES) to determine the presence of pathogenic variants related with actionable childhood onset diseases, allowing the specialist to improve medical care. Knowing this risk allows the implementation of appropriate monitoring or treatment in each case before the symptoms appears.


Your Reports

What Can I Expect to Receive with MyNewborn Screening?

All families will receive a comprehensive report with detailed information about the variants detected and the implications for the newborn. Families will have access to a trusted genetic counselor who will interpret and discuss the results.

Pathogenic variants and probably pathogenic variants classified based on American College of Medical Genetics and Genomics (ACMG) (PMID: 25741868) guidelines are reported.

Company Comparison

Newborn Insights Panel

ViaCord Americord
Number of genes analyzed 270 400
Genetic conditions screened for 250+ 390
Personalized findings report
Genetic counselor


Frequently Asked Questions

How does genomic sequencing help my family?

Whole genome sequencing allows all your genetic material to be read by creating a library about you. In this way you will be able to know the relevant information today to prevent and have access to updates in the future, accessing your library again. This means that from now on you can personalize, with the help of your specialist, your health care based on what makes you unique: your DNA.

Why should I purchase myNewborn?

MyNewborn offers early screening for genetic diseases that appear during the first stages of life, providing key information for preventive management, diet or early treatment. The test complements the conventional heel prick test, improving clinical utility. The test is indicated for newborns and children in the first years of life who do not present symptoms of genetic disease and is performed on blood or by saliva.

How does the myNewborn test work?

MyNewborn is a genetic sequencing test that is performed from a small sample of your baby's cord blood. We sequence the entire exome (Whole Exome Sequencing) and issue a results report, the impact of which must be assessed by a specialist. All our tests include pre- and post-test genetic counseling.

How long does it take to receive my results?

The entire process from receiving your sample, analyzing the information, and producing your newborn's results takes up to 8 weeks. The estimated delivery time varies because every person’s genomic information is unique and may require different degrees of analysis.

Is Genomic Testing covered by my insurance?

You may be able to pay for the test via your FSA or HSA account. 

Are there any states genomic services are not offered?

Yes, Alaska, California, New York, and Washington DC. These states have restrictions and regulations that prevent Americord from offering genomic services to individuals who have blood or saliva collected for genomic testing in these states.

If you are a resident of these restricted states, but deliver or provide a maternal blood outside of these states you can purchase Genomic services.